Court Opinion

ID: 4681245
Source: CourtListenerOpinion
Date Created: 2021-04-27 16:02:06.829923+00
Date Added: 2024-06-11T08:04:00.468365
License: Public Domain

In the United States Court of Federal Claims
                                  OFFICE OF SPECIAL MASTERS
                                           No. 17-531V
                                      Filed: March 31, 2021
                                          UNPUBLISHED

    TARA ELVIRA, on behalf of D.E.,                                 Special Master Horner

                         Petitioner,
    v.                                                              Interim Attorneys’ Fees and
                                                                    Costs Decision; Reasonable
    SECRETARY OF HEALTH AND                                         Hourly Rate
    HUMAN SERVICES,

                        Respondent.

Mark T. Sadaka, Sadaka Associates LLC, Englewood, NJ, for petitioner.
Colleen Clemons Hartley, U.S. Department of Justice, Washington, DC, for respondent.

           DECISION AWARDING INTERIM ATTORNEYS’ FEES AND COSTS1

       On April 14, 2017, petitioner filed a petition under the National Childhood Vaccine
Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that her minor child, D.E., suffered
atypical Kawasaki disease caused or significantly aggravated by D.E.’s February 26,
2015 Prevnar-13 (pneumococcal conjugate) vaccination. (ECF No. 1.) On February
26, 2021, petitioner moved for an award of interim attorneys’ fees and costs in the
amount of $56,990.57. (ECF No. 62.) In response, respondent deferred to the special
master regarding both the amount and appropriateness of an award of interim attorneys’
fees and costs. (ECF No. 63.) For the reasons discussed below, petitioner is awarded
interim attorneys’ fees and costs in the full amount of $56,990.57.

1 Because this decision contains a reasoned explanation for the special master’s action in this case, it will
be posted on the United States Court of Federal Claims’ website in accordance with the E-Government
Act of 2002. See 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic
Government Services). This means the decision will be available to anyone with access to the
Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact
medical or other information the disclosure of which would constitute an unwarranted invasion of privacy.
If the special master, upon review, agrees that the identified material fits within this definition, it will be
redacted from public access.
   I.     Procedural History

        This case was originally assigned to Special Master Millman. (ECF No. 4.) On
June 6, 2017, Special Master Millman issued an Order to Show Cause, ordering
petitioner to address the severity requirement during a status conference. (ECF No. 8.)
Such status conference was held on July 10, 2017, and Special Master Millman allowed
petitioner to brief the issue of the six-months sequalae statutory requirement. (ECF No.
9.) Petitioner filed an amended petition and response to the Order to Show Cause on
September 15, 2017. (ECF Nos. 12-13.)

        Special Master Millman found that petitioner’s argument that D.E. experienced
more than six months of residual effects sufficient and ordered petitioner to file an
expert report supporting her claim. (ECF No. 24.) On September 10, 2018, petitioner
filed an expert report from Dr. M. Eric Gershwin. (ECF No. 30.) Thereafter, respondent
filed expert reports from Drs. Andrew J. MacGinnitie and Scott Yeager in response.
(ECF Nos. 33-36.) Additionally, respondent filed his Rule 4(c) report, recommending
against compensation. (ECF No. 37.)

       This case was reassigned to my docket on June 6, 2019. (ECF No. 41.) On
September 5, 2019, I held a Rule 5 conference and issued a subsequent order
indicating that a supplemental report from Dr. Gershwin would be necessary to proceed.
(ECF No. 45.)

       On February 20, 2020, petitioner filed a supplemental report from Dr. Gershwin.
(ECF No. 48.) Respondent filed an additional report from Dr. MacGinnitie on March 31,
2020 and petitioner provided a further report from Dr. Gershwin on December 30, 2020.
(ECF Nos. 51, 59.) On February 3, 2021, respondent filed a joint status report,
indicating that the parties “do not believe that the case is ripe for a ruling on the record,”
and requesting an additional opportunity for respondent to file a responsive
supplemental report from Dr. MacGinnitie. (ECF No. 61.)

       Petitioner filed the instant motion for interim attorneys’ fees and costs on
February 26, 2021, respondent filed his response on March 2, 2021, and petitioner filed
her reply on March 3, 2021. (ECF Nos. 62-64.) Accordingly, petitioner’s motion for
interim attorneys’ fees and costs is now ripe for resolution.

   II.    An Award of Interim Attorneys’ Fees and Costs is Appropriate

       Section 15(e)(1) of the Vaccine Act allows for the special master to award
“reasonable attorneys' fees, and other costs.” § 300aa–15(e)(1)(A)–(B). Even if their
claim is unsuccessful, petitioners are entitled to an award of reasonable attorneys’ fees
and costs if the special master finds that the petition was filed in good faith and with a
reasonable basis. Avera v. Sec'y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed.
Cir. 2008). The Federal Circuit has additionally concluded that interim fee awards are
permissible and appropriate under the Vaccine Act. Shaw v. Sec’y of Health & Human
Servs., 609 F.3d 1372 (Fed. Cir. 2010); Avera, 515 F.3d at 1352. In Avera, the Federal

                                              2
Circuit held that, “[i]nterim fees are particularly appropriate in cases where proceedings
are protracted and costly experts must be retained.” Avera, 515 F.3d at 1352. In
denying an interim fee award, the Avera court explained that “[t]he amount of fees here
was not substantial; appellants had not employed any experts; and there was only a
short delay in the award pending the appeal.” Id. In Shaw, the Federal Circuit clarified
that “where the claimant establishes that the cost of litigation has imposed an undue
hardship and there exists a good faith basis for the claim, it is proper for the special
master to award interim attorneys’ fees.” 609 F.3d at 1375.

       Respondent did not contest petitioner’s good faith and reasonable basis for this
claim, but instead deferred to my judgment. (ECF No. 63, p. 2.) Upon review of the
record, there is no evidence that this petition was brought in bad faith, and further,
based on the facts and expert presentation of this case thus far, petitioner had a
reasonable basis to file her claim. Petitioner’s request for interim attorneys’ fees and
costs is made after more than four years of litigation within the entitlement phase of this
case and after petitioner incurred costs for providing multiple expert reports to support
her claim. Moreover, the time to ultimate resolution of this case remains unknown.
Accordingly, I find that petitioner’s request for an award for interim attorneys’ fees and
costs is reasonable at this juncture.

   III.   Reasonableness of the Requested Award

          a. Attorneys’ Fees

        It is “well within the special master’s discretion” to determine the reasonableness
of fees. Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1521-22 (Fed. Cir.
1993); see also Hines v. Sec’y of Health & Human Servs., 22 Cl. Ct. 750, 753 (1991)
(“[T]he reviewing court must grant the special master wide latitude in determining the
reasonableness of both attorneys’ fees and costs.”). The Federal Circuit has approved
the lodestar approach to determine reasonable attorneys’ fees and costs under the
Vaccine Act. Avera, 515 F.3d at 1347. This is a two-step process. Id. at 1347-48.
First, a court determines an “initial estimate . . . by ‘multiplying the number of hours
reasonably expended on the litigation times a reasonable hourly rate.’” Id. (quoting
Blum v. Stenson, 465 U.S. 886, 888 (1984)). Second, the court may make an upward
or downward departure from the initial calculation of the fee award based on specific
findings. Id. at 1348.

        A reasonable hourly rate is “the prevailing market rate defined as the rate
prevailing in the community for similar services by lawyers of reasonably comparable
skill, experience, and reputation.” Avera, 515 F.3d at 1348 (citation and quotation
omitted). The decision in McCulloch provides a further framework for consideration of
appropriate ranges for attorneys’ fees based upon the experience of the practicing
attorney. McCulloch v. Sec’y of Health & Human Servs., No. 09-293V, 2015 WL
5634323, at *19 (Fed. Cl. Spec. Mstr. Sept. 1, 2015), motions for recons. denied, 2015
WL 6181910 (Fed. Cl. Spec. Mstr. Sept. 21, 2015). The Office of Special Masters has

                                             3
subsequently updated the McCulloch rates, and the Attorneys’ Forum Hourly Rate Fee
Schedules for 2015-2016, 2017, 2018, 2019, 2020, and 2021 can be accessed online.2

        Here, petitioner is seeking $43,327.31 in interim attorneys’ fees for work
performed from 2016 through 2021. I have reviewed the billing records submitted with
petitioner’s request, and in my experience, the hourly rates for attorney time and
paralegal time pertaining to 2016 through 2020 are reasonable and in accord with prior
awards made by other special masters for the. Petitioner requested an increase in
hourly rates for 2021 for both attorney and paralegal time. Mr. Sadaka is requesting an
hourly rate of $444 for 2021 and an hourly of rate of $172 for his paralegal for 2021.
(ECF No. 62, p. 4.) Petitioner indicates that the new rates are in accord with the
McCulloch reasoning and the forum rates set by the Office of Special Masters. (Id.)
The requested rates are consistent with the fee schedule established by the Office of
Special Masters and therefore, I find the new hourly rates for 2021 to be reasonable.

        Turning next to the hours billed, special masters may rely on their experience
within the Vaccine Program to determine the reasonable number of hours expended.
Wasson v. Sec’y of Health & Human Servs., 24 Cl. Ct. 482, 483 (1991), rev’d on other
grounds and aff’d in relevant part¸ 988 F.2d 131 (Fed. Cir. 1993). Upon my review, the
hours that have been billed in this case are reasonable.

           b. Interim Attorneys’ Costs

        Attorneys’ costs must be reasonable as well. See Perreira v. Sec’y of Health &
Human Servs., 27 Fed. Cl. 29, 34 (1992) (“The conjunction ‘and’ conjoins both
‘attorneys’ fees’ and ‘other costs’ and the word ‘reasonable’ necessarily modifies both.
Not only must any request for reimbursement of attorneys’ fees be reasonable, so also
must any request for reimbursement of costs.”). An expert retained by the petitioner in
the Vaccine Program will only be compensated at a reasonable hourly rate, and the
petitioners have the burden of demonstrating that the expert costs incurred were
reasonable. Simon v. Sec’y of Health & Human Servs., No. 05-941V, 2008 WL 623833,
at *2 (Fed. Cl. Spec. Mstr. Feb. 21, 2008). In this case, petitioner seeks $13,769.33 in
interim attorneys’ costs.

       In this case, petitioner seeks $13,663.26 in interim attorneys’ costs, including the
cost of obtaining medical records and expert costs billed by Dr. Gershwin. Dr.
Gershwin’s hourly rate of $500 per hour is comparable to what has been awarded in
other recent cases. See e.g., Mills v. Sec’y of Health & Human Servs., No. 17-457V,
2021 WL 798823 (Fed. Cl. Spec. Mstr. Feb. 4, 2021); Lewis v. Sec'y of Health & Hum.
Servs., No. 16-1604V, 2020 WL 4578584 (Fed. Cl. Spec Mstr. July 8, 2020); Soltys v.
Sec'y of Health & Hum. Servs., No. 17-401V, 2020 WL 5049411 (Fed. Cl. Spec. Mstr.

2 Each of the Fee Schedules for 2015 through 2021 can be accessed at
http://www.cofc.uscourts.gov/node/2914. The hourly rates contained within the schedules are derived
from the decision in McCulloch, 2015 WL 5634323. The schedules for 2017, 2018, 2019, 2020, and 2021
are adjusted for inflation using the Producer Price Index for Offices of Lawyers (“PPI-OL”).

                                                 4
June 26, 2020); Santoroski v. Sec'y of Health & Hum. Servs., No. 15-1294V, 2019 WL
3577842 (Fed. Cl. Spec. Mstr. June 8, 2020). Upon review, I find that the total amount
requested is reasonable for the work performed by Dr. Gershwin in this case.
Additionally, the remaining costs are well-documented and shall be awarded in full for a
total award of $13,663.26.

    IV.      Conclusion

      In light of the above, petitioner’s motion for an award of interim attorneys’ fees
and costs is hereby GRANTED. Petitioner is awarded $56,990.57, representing
$43,327.31 in interim attorneys’ fees and $13,663.26 in interim attorneys’ costs.
Accordingly, I award a total of $56,990.57 as a lump sum in the form of a check
payable to petitioner and her counsel, Mark T. Sadaka.

          The clerk of the court shall enter judgment in accordance herewith.3

IT IS SO ORDERED.

                                                           s/Daniel T. Horner
                                                           Daniel T. Horner
                                                           Special Master

3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.

                                                      5